Key statistics
As of last trade Chromocell Therapeutics Corp (CHRO:ASQ) traded at 0.6113, 4.50% above its 52-week low of 0.585, set on Aug 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.61 |
---|---|
High | 0.6395 |
Low | 0.61 |
Bid | 0.6112 |
Offer | 0.66 |
Previous close | 0.599 |
Average volume | 310.58k |
---|---|
Shares outstanding | 5.77m |
Free float | 1.11m |
P/E (TTM) | -- |
Market cap | 3.45m USD |
EPS (TTM) | -1.66 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 20:01 BST.
More ▼
Announcements
- Chromocell to Participate in the Virtual Investor Lunch Break Series
- Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024
- Chromocell Issues Letter to Stockholders from Chief Executive Officer
- Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
- Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
- Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
- Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
- Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
- Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
More ▼